99% Savings - Buy Just @1 Rs X
Arvast F 5 Tablet is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Arvast F 5 Tablet have also been explained below.
The optimal dosage of Arvast F 5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Arvast F 5 Tablet include Nausea or vomiting, Headache, Constipation. Besides the aforementioned side effects, there are other adverse effects of Arvast F 5 Tablet as well, which are listed below. Usually, these side effects of Arvast F 5 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Arvast F 5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Arvast F 5 Tablet related warnings talks about Arvast F 5 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Arvast F 5 Tablet since this can cause severe adverse effects.
Drug interactions for Arvast F 5 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Arvast F 5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Arvast F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Arvast F 5 Tablet safe for pregnant women?
Arvast F may have some side effects during pregnancy. Pregnant women should discontinue the use of Arvast F, and talk to their doctor, if they notice any discomfort.
Is the use of Arvast F 5 Tablet safe during breastfeeding?
Arvast F can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Arvast F 5 Tablet on the Kidneys?
Arvast F has very mild side effects on the kidneys.
What is the effect of Arvast F 5 Tablet on the Liver?
Very few cases of side effects of Arvast F on the liver have been reported.
What is the effect of Arvast F 5 Tablet on the Heart?
The heart can be affected by Arvast F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Arvast F 5 Tablet unless your doctor advises you to do so -
Is this Arvast F 5 Tablet habit forming or addictive?
No, there is no any evidence that Arvast F 5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Arvast F 5 Tablet, you should not drive or work on any heavy machine, as Arvast F 5 Tablet can make you drowsy.
Is it safe?
Arvast F 5 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Arvast F 5 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Arvast F 5 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Arvast F 5 Tablet together with food.
Interaction between Alcohol and Arvast F 5 Tablet
Information about the interaction of Arvast F 5 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650